Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 2 min 10 sec ago

Aurora Spine Announces First Surgery Using Zip Graft(TM) Bone Dowel

Fri, 07/25/2014 - 21:11
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the first U.S. surgery using the ZIP Graft ™ pre-packaged sterile bone dowel. The surgery was performed at Madison County Hospital in ...
Devices, Neurosurgery, Orthopaedic
Aurora Spine, ZIP Graft, bone dowel, spine surgery

European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA(R) (ibrutinib) for Treatment of Two Blood Cancers

Fri, 07/25/2014 - 13:15
SUNNYVALE, Calif., July 25, 2014 -- (Healthcare Sales & Marketing Network) -- Pharmacyclics, Inc. (PCYC) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recomm...
Biopharmaceuticals, Oncology, Regulatory
Pharmacyclics, Janssen, IMBRUVICA, ibrutinib

Guided Therapeutics Files PMA Amendment with FDA for LuViva(R) Advanced Cervical Scan

Fri, 07/25/2014 - 13:09
NORCROSS, Ga.--(Healthcare Sales & Marketing Network)--Guided Therapeutics, Inc. (GTHP) (GTHP) today announced that it has filed an amendment to its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the LuViva® A...
Devices, Diagnostics, FDA
Guided Therapeutics, LuViva, Advanced Cervical Scan, spectroscopy

Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR(R) (sorafenib) in Patients with Advanced Breast Cancer

Fri, 07/25/2014 - 13:01
WHIPPANY, N.J. and SOUTH SAN FRANCISCO, Calif., July 25, 2014 -- (Healthcare Sales & Marketing Network) -- Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary (AMGN), today announced that an investigational Phase 3 trial of NEXAVAR® (s...
Biopharmaceuticals, Oncology
Bayer HealthCare, Onyx Pharmaceuticals, Amgen, NEXAVAR, sorafenib, breast cancer

Bioheart Announces World's First Combination Stem Cell Treatment

Thu, 07/24/2014 - 14:59
SUNRISE, FL--(Healthcare Sales & Marketing Network) - Bioheart, Inc. (OTCQB: BHRT) announced today that it has completed the world's first combination stem cell treatment with Magnum Cell Therapies (Magnum) in Honduras. A patient with congestive heart fai...
Regenerative Medicine, Cardiology
Bioheart, AdipoCell, MyoCell, stem cell, heart failure

Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system

Thu, 07/24/2014 - 14:53
Transducer-plus-tablet display delivers excellent image quality, making ultrasound available anytime, in a wide range of clinical environments for OB patients ANDOVER, Mass., July 24, 2014 -- (Healthcare Sales & Marketing Network) -- Royal Philips (NYS...
Devices, FDA
Royal Philips, VISIQ, ultrasound, imaging

Boston Scientific Receives CE Mark For Agent(TM) Drug-Coated Balloon

Thu, 07/24/2014 - 14:48
Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease MARLBOROUGH, Mass., July 23, 2014 -- (Healthcare Sales & Marketing Network) -- Continuing to advance the development of innovative treatment opti...
Devices, Interventional Cardiology, Regulatory
Boston Scientific, Paclitaxel, drug-coated balloon, PTCA, balloon catheter

FDA Approves Eagle Pharmaceuticals’ Ryanodex(R) for the Treatment of Malignant Hyperthermia

Wed, 07/23/2014 - 13:08
Novel Antidote Enables Quicker Response to Inherited Life-Threatening Condition Orphan Drug Designation may Provide Eagle Seven Years Market Exclusivity First Self Marketed Drug for Eagle with Shipments to begin Shortly WOODCLIFF LAKE, N.J.--(Heal...
Biopharmaceuticals, FDA
Eagle Pharmaceuticals, Ryanodex, dantrolene, malignant hyperthermia

Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen

Wed, 07/23/2014 - 12:59
Strengthens Leadership Position in Treatments for Hunter syndrome and Commitment to MPS II Patient Community LEXINGTON, Massachusetts, July 23, 2014 -- (Healthcare Sales & Marketing Network) -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty b...
Biopharmaceuticals, Neurology, Licensing
Shire plc, ArmaGen , AGT-182, enzyme replacement therapy, Hunter syndrome

Teleflex Signs New Agreement with Amerinet for Surgical Instruments

Wed, 07/23/2014 - 12:53
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with Amerinet, a national healthcare solutions organization, for a co...
Devices, Group Purchasing
Teleflex, Amerinet, Pilling, KMedic

Occlutech Wins Invalidation of St Jude Patent

Wed, 07/23/2014 - 12:48
JENA, Germany, July 23, 2014 -- (Healthcare Sales & Marketing Network) -- Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced that it has successfully obtained a ruling by the U.K...
Devices, Interventional Cardiology, Litigation
Occlutech, St Jude, AGA Medical

Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates

Tue, 07/22/2014 - 13:44
First-in-class, proprietary synthetic biology platform leveraged for application across multiple diseases CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Synlogic, Inc., a biotechnology company focused on the development of therapeutic microbe...
Biopharmaceuticals, Venture Capital
Synlogic, microbial engineering

Teleflex Receives FDA Clearance for ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter

Tue, 07/22/2014 - 13:38
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its ARROW-Clark™ VectorFlow™ Chronic H...
Devices, FDA
Teleflex, ARROW-Clark, VectorFlow, Hemodialysis Catheter

Covidien Announces Leadership Appointment

Tue, 07/22/2014 - 13:33
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced that Bryan Hanson, who currently serves as group president, Medical Devices & U.S., will be elevated to the newly created position of group president, Covidien, eff...
Devices, Personnel

Multi-Center Trial Shows Significant Pain Relief for Spine Cancer Patients Following Targeted Radiofrequency Ablation Treatment

Tue, 07/22/2014 - 13:28
SAN JOSE, Calif.--(Healthcare Sales & Marketing Network)--DFINE®, Inc., a market leader in the minimally invasive treatment of spinal diseases, today announced the publication of a multi-center study in the July/August issue of Pain Physician Journal, ...
Devices, Oncology
DFINE Inc, t-RFA, Targeted Radiofrequency Ablation, Tumor Ablation

FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer

Tue, 07/22/2014 - 13:21
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics Lic...
Biopharmaceuticals, Oncology, FDA
Genentech, Avastin, bevacizumab, ovarian cancer

CorMatrix(R) Reports FDA Clearance of CorMatrix ECM(R) for Vascular Repair

Mon, 07/21/2014 - 15:17
ROSWELL, Ga.--(Healthcare Sales & Marketing Network)--CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix® ECM® for Vascular Repair. The CorMatrix ECM for Vascul...
Devices, Regenerative Medicine, FDA
CorMatrix Cardiovascular, CorMatrix ECM, Vascular Repair

Varian Medical Systems Receives FDA 510(k) Clearance for Calypso(R) Soft Tissue Beacon(R) Transponder

Mon, 07/21/2014 - 15:12
New clearance expands the indications for which clinicians will be able to use Varian's Calypso real-time tracking device for monitoring motion during radiotherapy treatments for cancer PALO ALTO, Calif., July 21, 2014 -- (Healthcare Sales & Marketing N...
Devices, Oncology, FDA
Varian Medical Systems, Calypso, soft tissue Beacon, radiotherapy, radiosurgery

Expanding Orthopedics Inc. has obtained FDA Clearance for its FLXfit(TM), the world's first 3D expandable interbody cage

Mon, 07/21/2014 - 15:09
EOI announces FDA Clearance of the FLXfit™, the only TLIF cage combining articulation and height expansion with lordotic angle correction. OR AKIVA, Israel, July 21, 2014 -- (Healthcare Sales & Marketing Network) -- Expanding Orthopedics Inc. (EOI), a ...
Devices, Orthopaedic, Neurosurgery, FDA
Expanding Orthopedics, FLXfit, interbody fusion

Zynex Announces Brian Alleman as Chief Financial Officer

Mon, 07/21/2014 - 15:05
LONE TREE, CO--(Healthcare Sales & Marketing Network) - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological d...
Devices, Neurology, Personnel
Zynex, NeuroDiagnostics, electrotherapy

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong